Restor3d is expected to acquire Conformis for $2.27 per share, according to an Aug. 21 news release. The deal was first announced in June.
Under the pending deal, Restor3d will acquire all of the outstanding stock shares of Conformis in cash. Conformis’ board of directors unanimously approved the transaction.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
